CAS RN: 545445-44-1
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
Product Availability
Choose a grade to view its available package options.
5 package records5 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250815 |
100g |
In stock |
Tianjin | Inquiry |
| Batchno.20250409 |
10g |
In stock |
Shanghai, Tianjin, Wuhan, Chengdu | Inquiry |
| Batchno.20250601 |
1g |
In stock |
Shanghai, Tianjin | Inquiry |
| Batchno.20251204 |
25g |
In stock |
Shanghai, Shenzhen | Inquiry |
| Batchno.20251231 |
5g |
In stock |
Shanghai, Wuhan, Chengdu | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 0.25g
- Available purity: ≥95%
- Inventory rows with stock: 2
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 545445-44-1
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
≥95% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
≥95% |
2
In Stock
|
Shenzhen |
Inquiry |
545445-44-1 / 5-morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-2,3-dihydropyridin-6-one
Standard CAS: 545445-44-1
Multi CAS: No
Basic Information
CAS
545445-44-1
Multi CAS
No
Molecular Formula
C20H25N3O3
Molecular Weight
355.400000
Exact Mass
355.189592
InChI
InChI=1S/C20H25N3O3/c24-19-5-1-2-10-22(19)16-6-8-17(9-7-16)23-11-3-4-18(20(23)25)21-12-14-26-15-13-21/h4,6-9H,1-3,5,10-15H2
InChIKey
SCVWQFDPLBFZAP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
26
Aromatic heavy atom count
6
Fraction Csp3
0.5
Rotatable bonds
3
H-bond acceptors
4
Molar refractivity
100.09
TPSA
53.09
LogP / Solubility
WLOGP
2.16
MLOGP
1.92
XLogP3
1.6
Consensus LogP
1.89
Log S (ESOL)
-3.37
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.03
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.12
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.36
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3